Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Hadassah Hebrew University Medical Center | RCV000991393 | SCV001142788 | likely pathogenic | Baller-Gerold syndrome; Rapadilino syndrome; Rothmund-Thomson syndrome type 2 | 2019-06-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001070944 | SCV001236224 | pathogenic | Baller-Gerold syndrome | 2019-03-25 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant has not been reported in the literature in individuals with RECQL4-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg347Profs*2) in the RECQL4 gene. It is expected to result in an absent or disrupted protein product. |